Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Lancartama Sejati Tbk. (TAMA) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Lancartama Sejati Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Lancartama Sejati Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 27.5K 24h volume), while Lancartama Sejati Tbk. trades at Rp174 (market cap 218.4B, 3.96M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Lancartama Sejati Tbk. is more actively traded (3.96M versus 27.5K). Which is the better fit depends on your goals.

DGNSTAMA
Market Cap
308B218.4B
Volume
27.5K3.96M
Lot
27539.58K
Turnover
6.23M690.53M
Average Price
226.59174.45
Value
6.23M690.53M
Indicative Equilibrium Price
230182
Indicative Equilibrium Volume
1105K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
TAMA
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Lancartama Sejati Tbk.

PT Lancartama Sejati Tbk (the Company) was established based on notary deed No. 12 dated June 01, 1990 of Sugiri Kadarisman, SH., notary in Jakarta.

Read more on TAMA